title: Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Tuddenham
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: Khalil G
authors.initials: KG
authors.lastname: Ghanem
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002511:Cephalosporins / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification; D011634:Public Health
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins
keywords: ANTIBIOTIC SENSITIVITY; GONORRHOEA; NEISSERIA GONORRHOEA